People

Noa Krawczyk
Noa Krawczyk, PhD
NYU Langone Health, Division of Epidemiology, Center for Opioid Epidemiology and Policy, Department of Population Health - Assistant Professor
Email: noa.krawczyk@nyulangone.org
Education
PhD, Mental Health, Johns Hopkins Bloomberg School of Public Health
BA, Biology, Hunter College at the City University of New York – Macaulay Honors College
Research Interests
Substance use, Opioids, Overdose, Health services, Mental health, Criminal justice, Treatment
BIO
Noa Krawczyk is an Assistant Professor in the Department of Population Health at NYU School of Medicine and a member of the Center for Opioid Epidemiology and Policy. She completed her PhD in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health, where she studied substance use epidemiology, and previously worked as a Fulbright research scholar to study treatment and health services among cocaine users in Brazil. Her research focuses on studying ways to address barriers to evidence-based treatment for opioid use disorders and improving quality and effectiveness of care, especially among vulnerable groups such as persons with criminal justice involvement. Her work centers on bridging research and practice by collaborating with health organizations, public health and government agencies and advancing science that can help inform evidence-based policies and practices that reduce harm and promote long term recovery.
Projects
Principal Investigator, Beyond Treatment Initiation: Enhancing Opioid Use Disorder Care Transitions Across Health System Touchpoints. Active
Principal Investigator, Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study. Active
Principal Investigator, NY MOVES: Evaluating the Impact of New York’s Methadone Outreach VEhicleS. Active
Principal Investigator, Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach. Active
Principal Investigator, Trends in Psychosis Related to Hospitalizations Among Youth Following Cannabis Legalization in Colorado. Completed
Publications

Recent

D'Adamo A, Genberg BL, Krawczyk N, Rudolph JE, Mehta SH, Tobian AAR, Patel EU (2025).
Trends injecting methamphetamine and opioids among people who inject drugs in the US
JAMA. doi: 10.1001/jama.2025.20347. PMCID: PMC12658752.

Borquez I, Bailey K, Laynor G, Toledo L, Bastos FI, Santaella-Tenorio J, Castillo-Carniglia A, Cerda M, Krawczyk N (2025).
Harm reduction services and interventions for people who use drugs (PWUD) in Latin America and the Caribbean (LAC) between 2013-2024: A scoping review protocol
PLoS One, 20 (11), e0334978. doi: 10.1371/journal.pone.0334978. PMCID: PMC12643314.

Krawczyk N, Scott J, Miller M, Coulter A, Ferguson A, Frank D, Jordan A, Joudrey P, Kimmel SD, Levander XA, Potee R, Roberts KE, Russell D, Simon R, Sue KL, Suen LW, Vincent L, Voyles N, Simon C (2025).
Envisioning a humane and accessible US methadone treatment system: Generating policy and practice recommendations from the Liberate Methadone movement
Substance Use & Addiction Journal [Epub 2026 Oct 26]. doi: 10.1177/29767342251377189.

Krawczyk N, Miller M, Bórquez I, Rutherford C, Bobashev G, Mund P, Keyes K, Cerda M, Jordan AE (2025).
Simulating the impact of methadone prescribing and pharmacy dispensing on opioid treatment and overdose in New York State: A study protocol for an agent-based modeling study
PLoS One, 20 (10), e0335123. doi: 10.1371/journal.pone.0335123. PMCID: PMC12543120.

Kapadia SN, Karan K, Zhang H, Chakraborty P, Krawczyk N, Bao Y (2025).
Developing and validating measures of take-home methadone with administrative data
Journal of Substance Use and Addiction Treatment [Epub 2025 Oct 20]. doi: 10.1016/j.josat.2025.209814.


Notable

Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D (2019).
Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap
Journal of Substance Abuse Treatment, 103, 1-8. doi: 10.1016/j.jsat.2019.05.002. PMCID: PMC6612429.

Krawczyk N, Picher CE, Feder KA, Saloner B (2017).
Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine
Health Affairs, 36 (12), 2046-2053. doi: 10.1377/hlthaff.2017.0890. PMCID: PMC6035729.

Dr. Krawczyk's MyBibliography Profile
Selected Press